 Megan Curran
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatology | 7 | 2024 | 107 | 2.580 |
Why?
| | Education, Medical, Graduate | 9 | 2025 | 443 | 2.340 |
Why?
| | Fellowships and Scholarships | 9 | 2025 | 279 | 1.670 |
Why?
| | Clinical Competence | 10 | 2025 | 1020 | 1.560 |
Why?
| | Pediatrics | 9 | 2025 | 1074 | 1.130 |
Why?
| | Dermatomyositis | 6 | 2020 | 26 | 1.120 |
Why?
| | Lupus Erythematosus, Systemic | 6 | 2022 | 247 | 0.930 |
Why?
| | Sjogren's Syndrome | 2 | 2021 | 49 | 0.880 |
Why?
| | Education, Distance | 1 | 2020 | 45 | 0.630 |
Why?
| | Scleroderma, Systemic | 3 | 2025 | 114 | 0.560 |
Why?
| | Hemorrhage | 1 | 2021 | 680 | 0.530 |
Why?
| | Arthritis, Juvenile | 2 | 2020 | 53 | 0.530 |
Why?
| | Educational Measurement | 1 | 2019 | 264 | 0.520 |
Why?
| | Mixed Connective Tissue Disease | 1 | 2015 | 10 | 0.490 |
Why?
| | Lupus Erythematosus, Discoid | 3 | 2022 | 8 | 0.470 |
Why?
| | Arthralgia | 2 | 2014 | 49 | 0.470 |
Why?
| | Mental Health | 3 | 2020 | 691 | 0.470 |
Why?
| | Lung Diseases | 1 | 2021 | 743 | 0.460 |
Why?
| | Program Evaluation | 1 | 2019 | 878 | 0.450 |
Why?
| | Antibodies, Antinuclear | 2 | 2019 | 66 | 0.420 |
Why?
| | Mycobacterium Infections | 1 | 2013 | 62 | 0.400 |
Why?
| | Arthritis | 1 | 2013 | 90 | 0.390 |
Why?
| | Shoes | 1 | 2012 | 18 | 0.390 |
Why?
| | Face | 1 | 2013 | 165 | 0.370 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1284 | 0.360 |
Why?
| | Leg | 1 | 2012 | 240 | 0.330 |
Why?
| | Child | 24 | 2025 | 20962 | 0.330 |
Why?
| | Mycobacterium tuberculosis | 1 | 2013 | 309 | 0.320 |
Why?
| | Joint Instability | 1 | 2012 | 167 | 0.320 |
Why?
| | Myositis | 2 | 2025 | 51 | 0.320 |
Why?
| | Competency-Based Education | 4 | 2023 | 71 | 0.320 |
Why?
| | Internship and Residency | 3 | 2023 | 1058 | 0.300 |
Why?
| | Knee Joint | 1 | 2012 | 375 | 0.300 |
Why?
| | Anxiety | 1 | 2015 | 976 | 0.300 |
Why?
| | Humans | 44 | 2025 | 129847 | 0.280 |
Why?
| | Depression | 1 | 2015 | 1323 | 0.260 |
Why?
| | Risk Assessment | 1 | 2015 | 3269 | 0.250 |
Why?
| | Psoriasis | 2 | 2024 | 87 | 0.250 |
Why?
| | Methotrexate | 2 | 2024 | 249 | 0.240 |
Why?
| | Diagnosis, Differential | 4 | 2014 | 1434 | 0.230 |
Why?
| | Age of Onset | 3 | 2021 | 494 | 0.220 |
Why?
| | Consensus | 6 | 2024 | 622 | 0.220 |
Why?
| | Stem Cell Transplantation | 1 | 2025 | 166 | 0.220 |
Why?
| | Raynaud Disease | 1 | 2023 | 6 | 0.220 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 374 | 0.210 |
Why?
| | Needs Assessment | 1 | 2024 | 357 | 0.190 |
Why?
| | Edema | 2 | 2013 | 124 | 0.190 |
Why?
| | Female | 21 | 2025 | 68829 | 0.180 |
Why?
| | Specialization | 1 | 2021 | 145 | 0.170 |
Why?
| | Trust | 1 | 2021 | 116 | 0.170 |
Why?
| | Ultrasonography | 1 | 2024 | 713 | 0.170 |
Why?
| | Purpura, Hyperglobulinemic | 1 | 2020 | 1 | 0.170 |
Why?
| | Videoconferencing | 1 | 2020 | 64 | 0.170 |
Why?
| | Purpura | 1 | 2020 | 15 | 0.170 |
Why?
| | Adalimumab | 1 | 2020 | 40 | 0.170 |
Why?
| | Ocular Motility Disorders | 1 | 2020 | 26 | 0.160 |
Why?
| | Dermatitis, Atopic | 1 | 2023 | 319 | 0.160 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2025 | 577 | 0.160 |
Why?
| | Extracellular Traps | 1 | 2020 | 49 | 0.160 |
Why?
| | Agammaglobulinemia | 1 | 2019 | 33 | 0.160 |
Why?
| | Physical Examination | 1 | 2020 | 234 | 0.160 |
Why?
| | Patient Simulation | 1 | 2019 | 34 | 0.150 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2015 | 3630 | 0.150 |
Why?
| | Rituximab | 1 | 2019 | 164 | 0.150 |
Why?
| | Adolescent | 13 | 2025 | 20451 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 240 | 0.150 |
Why?
| | Child Behavior | 1 | 2020 | 236 | 0.150 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 428 | 0.140 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3089 | 0.140 |
Why?
| | Dermatology | 1 | 2019 | 117 | 0.140 |
Why?
| | United States | 6 | 2025 | 13913 | 0.140 |
Why?
| | Professional Competence | 1 | 2018 | 96 | 0.140 |
Why?
| | Disability Evaluation | 1 | 2018 | 285 | 0.130 |
Why?
| | Antirheumatic Agents | 1 | 2019 | 280 | 0.130 |
Why?
| | Steroids | 2 | 2020 | 158 | 0.130 |
Why?
| | Parents | 2 | 2025 | 1319 | 0.130 |
Why?
| | Patient Care Planning | 1 | 2017 | 146 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2020 | 507 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.120 |
Why?
| | Internet | 1 | 2020 | 620 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1119 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2021 | 611 | 0.120 |
Why?
| | Practice Guidelines as Topic | 3 | 2025 | 1514 | 0.110 |
Why?
| | Neutrophils | 1 | 2020 | 1209 | 0.110 |
Why?
| | Endocrinology | 2 | 2021 | 74 | 0.110 |
Why?
| | Laryngeal Diseases | 1 | 2013 | 29 | 0.100 |
Why?
| | Male | 15 | 2025 | 63759 | 0.100 |
Why?
| | Hypothyroidism | 1 | 2013 | 70 | 0.100 |
Why?
| | Myocarditis | 1 | 2014 | 98 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2020 | 1070 | 0.100 |
Why?
| | Arthritis, Reactive | 1 | 2012 | 8 | 0.100 |
Why?
| | Patellofemoral Joint | 1 | 2012 | 9 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1500 | 0.100 |
Why?
| | Synovial Fluid | 1 | 2012 | 66 | 0.100 |
Why?
| | Flatfoot | 1 | 2012 | 12 | 0.100 |
Why?
| | Telemedicine | 1 | 2020 | 792 | 0.090 |
Why?
| | Eosinophilia | 1 | 2014 | 204 | 0.090 |
Why?
| | Dyspnea | 1 | 2013 | 239 | 0.090 |
Why?
| | Gestational Age | 1 | 2014 | 876 | 0.090 |
Why?
| | Arthritis, Infectious | 1 | 2012 | 59 | 0.090 |
Why?
| | Sarcoidosis | 1 | 2013 | 157 | 0.090 |
Why?
| | North America | 2 | 2024 | 294 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1274 | 0.090 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 381 | 0.080 |
Why?
| | Child Development | 1 | 2014 | 459 | 0.080 |
Why?
| | Evoked Potentials, Auditory | 1 | 2011 | 179 | 0.080 |
Why?
| | Speech Perception | 1 | 2011 | 83 | 0.080 |
Why?
| | Patient Selection | 2 | 2025 | 660 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5437 | 0.080 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1016 | 0.070 |
Why?
| | Disorders of Sex Development | 1 | 2008 | 38 | 0.070 |
Why?
| | Cost of Illness | 2 | 2020 | 277 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 439 | 0.070 |
Why?
| | Quality of Life | 3 | 2025 | 2695 | 0.070 |
Why?
| | Learning | 1 | 2011 | 403 | 0.070 |
Why?
| | Registries | 3 | 2020 | 1903 | 0.060 |
Why?
| | Child, Preschool | 5 | 2024 | 10522 | 0.060 |
Why?
| | Pain | 1 | 2012 | 791 | 0.060 |
Why?
| | Time Factors | 3 | 2025 | 6550 | 0.060 |
Why?
| | Infant | 3 | 2014 | 9018 | 0.060 |
Why?
| | Transplantation, Autologous | 1 | 2025 | 213 | 0.060 |
Why?
| | Dermatitis | 1 | 2024 | 19 | 0.060 |
Why?
| | Acne Vulgaris | 1 | 2024 | 27 | 0.050 |
Why?
| | Social Support | 1 | 2008 | 587 | 0.050 |
Why?
| | Certification | 1 | 2024 | 95 | 0.050 |
Why?
| | Accreditation | 1 | 2023 | 80 | 0.050 |
Why?
| | Dermatologic Agents | 1 | 2024 | 65 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2677 | 0.050 |
Why?
| | Neurons | 1 | 2011 | 1509 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2022 | 14553 | 0.050 |
Why?
| | Administrative Personnel | 1 | 2021 | 30 | 0.050 |
Why?
| | Infectious Disease Medicine | 1 | 2021 | 12 | 0.050 |
Why?
| | Hematology | 1 | 2021 | 15 | 0.050 |
Why?
| | Nocardia Infections | 1 | 2021 | 9 | 0.050 |
Why?
| | Patient Handoff | 1 | 2021 | 32 | 0.050 |
Why?
| | Pediatric Emergency Medicine | 1 | 2021 | 19 | 0.050 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 34 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2021 | 35 | 0.040 |
Why?
| | Neonatology | 1 | 2021 | 23 | 0.040 |
Why?
| | Adolescent Medicine | 1 | 2021 | 36 | 0.040 |
Why?
| | Psychometrics | 1 | 2025 | 701 | 0.040 |
Why?
| | Language | 1 | 2023 | 283 | 0.040 |
Why?
| | Pulmonary Medicine | 1 | 2021 | 80 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 2021 | 123 | 0.040 |
Why?
| | Self Report | 1 | 2025 | 800 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 300 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5085 | 0.040 |
Why?
| | Family Relations | 1 | 2020 | 87 | 0.040 |
Why?
| | Adult | 5 | 2025 | 35634 | 0.040 |
Why?
| | Europe | 1 | 2020 | 363 | 0.040 |
Why?
| | Dermatologists | 1 | 2019 | 4 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2628 | 0.040 |
Why?
| | Rheumatologists | 1 | 2019 | 15 | 0.040 |
Why?
| | Medicine | 1 | 2021 | 119 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 822 | 0.040 |
Why?
| | Medical Oncology | 1 | 2021 | 268 | 0.040 |
Why?
| | Gastroenterology | 1 | 2021 | 177 | 0.040 |
Why?
| | Resilience, Psychological | 1 | 2020 | 127 | 0.040 |
Why?
| | Depression, Postpartum | 1 | 2000 | 127 | 0.040 |
Why?
| | Sleep Deprivation | 1 | 2000 | 171 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 5444 | 0.040 |
Why?
| | Focus Groups | 1 | 2020 | 450 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2000 | 236 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.040 |
Why?
| | Curriculum | 1 | 2024 | 928 | 0.030 |
Why?
| | Phenotype | 2 | 2017 | 3062 | 0.030 |
Why?
| | Infant, Newborn | 3 | 2015 | 5772 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 851 | 0.030 |
Why?
| | Consensus Development Conferences as Topic | 1 | 2017 | 27 | 0.030 |
Why?
| | Depressive Disorder, Major | 1 | 2000 | 345 | 0.030 |
Why?
| | Delphi Technique | 1 | 2018 | 227 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 482 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2021 | 735 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 618 | 0.030 |
Why?
| | Qualitative Research | 1 | 2022 | 1235 | 0.030 |
Why?
| | Panniculitis, Lupus Erythematosus | 1 | 2015 | 1 | 0.030 |
Why?
| | Oral Ulcer | 1 | 2015 | 10 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 851 | 0.030 |
Why?
| | Risk Factors | 2 | 2019 | 9801 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1597 | 0.030 |
Why?
| | Lupus Nephritis | 1 | 2015 | 49 | 0.030 |
Why?
| | Caudate Nucleus | 1 | 2014 | 20 | 0.030 |
Why?
| | Putamen | 1 | 2014 | 22 | 0.030 |
Why?
| | Globus Pallidus | 1 | 2014 | 23 | 0.030 |
Why?
| | Lateral Ventricles | 1 | 2014 | 36 | 0.030 |
Why?
| | Hypereosinophilic Syndrome | 1 | 2014 | 10 | 0.030 |
Why?
| | Brain Stem | 1 | 2014 | 100 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 456 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2020 | 900 | 0.030 |
Why?
| | Thalamus | 1 | 2014 | 100 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1951 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3161 | 0.030 |
Why?
| | Rheumatic Diseases | 1 | 2014 | 69 | 0.030 |
Why?
| | Amygdala | 1 | 2014 | 192 | 0.030 |
Why?
| | Societies, Medical | 1 | 2017 | 759 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2564 | 0.020 |
Why?
| | Cerebellum | 1 | 2014 | 218 | 0.020 |
Why?
| | Hip Joint | 1 | 2014 | 158 | 0.020 |
Why?
| | Physical Exertion | 1 | 2013 | 210 | 0.020 |
Why?
| | Mass Screening | 1 | 2019 | 1192 | 0.020 |
Why?
| | Reaction Time | 1 | 2013 | 411 | 0.020 |
Why?
| | Language Tests | 1 | 2011 | 33 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 3397 | 0.020 |
Why?
| | Vocabulary | 1 | 2011 | 46 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 640 | 0.020 |
Why?
| | Magnetoencephalography | 1 | 2011 | 128 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3773 | 0.020 |
Why?
| | Heart Diseases | 1 | 2014 | 352 | 0.020 |
Why?
| | Thrombosis | 1 | 2014 | 349 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 739 | 0.020 |
Why?
| | Skin | 1 | 2015 | 725 | 0.020 |
Why?
| | Hippocampus | 1 | 2014 | 844 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 716 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2016 | 0.020 |
Why?
| | Kidney | 1 | 2015 | 1383 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2724 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 575 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1468 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7158 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3384 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 12467 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4896 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2012 | 10241 | 0.010 |
Why?
| | Obesity | 1 | 2013 | 2885 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2000 | 416 | 0.010 |
Why?
| | Pregnancy | 1 | 2000 | 6423 | 0.000 |
Why?
|
|
Curran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|